Oppenheimer raised the firm’s price target on Zurn Elkay Water (ZWS) to $52 from $48 and keeps an Outperform rating on the shares after hosting investor meetings with CFO Dave Pauli and Director of FP&A Bryan Wendlandt, with Q&A focused on demand trends across end markets, relative project visibility, continued/robust growth of the Elkay drinking water platform, and the team’s M&A strategy. The firm came away highly confident in Zurn Elkay’s ability to meet near-term estimates and sustain core momentum into 2026. Combining that setup with significant dry powder, Oppenheimer likes Zurn’s prospects for continued double-digit earnings/cash flow growth, appreciate the stock’s appeal and investability for an increasingly needle-moving percentage of the market, and see valuation as relatively supportive.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZWS: